Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1990 Oct;137(4):871–882.

Accelerated arteriosclerosis in heart transplant recipients is associated with a T-lymphocyte-mediated endothelialitis.

R H Hruban 1, W E Beschorner 1, W A Baumgartner 1, S M Augustine 1, H Ren 1, B A Reitz 1, G M Hutchins 1
PMCID: PMC1877542  PMID: 1699422

Abstract

Accelerated arteriosclerosis has emerged as a major life-threatening complication in long-term survivors of heart transplantation. It has been proposed that accelerated arteriosclerosis is an immune-mediated complication of rejection. We observed a striking endothelialitis in the coronary arteries of two explanted hearts obtained from patients with severe transplant-related accelerated arteriosclerosis. This finding prompted us to review the pathologic changes in the coronary arteries of 23 autopsied patients who had received heart transplants. The infiltrate in these vessels was characterized using immunohistochemical stains for lymphocytes (CD45), macrophages (MAC-387), T lymphocytes (CD45RO), B lymphocytes (L-26), and smooth muscle cells (actin). In addition, a full panel of monoclonal antibodies was used on the fresh-frozen tissue available from one of the two explanted hearts. Ten of the eleven recipients with accelerated arteriosclerosis had a moderate to marked lymphocytic endothelialitis compared to 3 of 14 without transplant-related arteriosclerosis (P less than 0.005). Immunohistochemical staining of the paraffin-embedded material demonstrated that most of the lymphocytes in the subendothelial space of these vessels were T lymphocytes and that this infiltrate was associated with an accumulation of macrophages and a proliferation of smooth muscle cells in the intima. In the explanted heart from which fresh-frozen tissue was available for more detailed cell typing, the T cells marked predominantly as cytotoxic T lymphocytes (CD8+, CD2+). These results suggest that accelerated arteriosclerosis may be mediated, in part, by a cytotoxic T-lymphocyte-directed endothelialitis.

Full text

PDF
871

Images in this article

873Figure 1
on p.873
875Figure 2
on p.875
876Figure 3
on p.876

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alonso D. R., Starek P. K., Minick C. R. Studies on the pathogenesis of atheroarteriosclerosis induced in rabbit cardiac allografts by the synergy of graft rejection and hypercholesterolemia. Am J Pathol. 1977 May;87(2):415–442. [PMC free article] [PubMed] [Google Scholar]
  2. Ballester M., Obrador D., Carrió I., Bordes R., Augé J. M., Crexells C., Oriol A., Padró J. M., Arís A., Caralps J. M. Reversal of rejection-induced coronary vasculitis detected early after heart transplantation with increased immunosuppression. J Heart Transplant. 1989 Sep-Oct;8(5):413–417. [PubMed] [Google Scholar]
  3. Becker D. M., Chamberlain B., Swank R., Hegewald M. G., Girardet R., Baughman K. L., Kwiterovich P. O., Pearson T. A., Ettinger W. H., Renlund D. Relationship between corticosteroid exposure and plasma lipid levels in heart transplant recipients. Am J Med. 1988 Nov;85(5):632–638. doi: 10.1016/s0002-9343(88)80234-1. [DOI] [PubMed] [Google Scholar]
  4. Bieber C. P., Hunt S. A., Schwinn D. A., Jamieson S. A., Reitz B. A., Oyer P. E., Shumway N. E., Stinson E. B. Complications in long-term survivors of cardiac transplantation. Transplant Proc. 1981 Mar;13(1 Pt 1):207–211. [PubMed] [Google Scholar]
  5. Bieber C. P., Stinson E. B., Shumway N. E., Payne R., Kosek J. Cardiac transplantation in man. VII. Cardiac allograft pathology. Circulation. 1970 May;41(5):753–772. doi: 10.1161/01.cir.41.5.753. [DOI] [PubMed] [Google Scholar]
  6. Billingham M. E. Cardiac transplant atherosclerosis. Transplant Proc. 1987 Aug;19(4 Suppl 5):19–25. [PubMed] [Google Scholar]
  7. Billingham M. E. Graft coronary disease: the lesions and the patients. Transplant Proc. 1989 Aug;21(4):3665–3666. [PubMed] [Google Scholar]
  8. Cerilli J., Holliday J. E., Fesperman D. P., Folger M. R. Antivascular endothelial cell antibody--its role in transplantation. Surgery. 1977 Feb;81(2):132–138. [PubMed] [Google Scholar]
  9. Chomette G., Auriol M., Cabrol C. Chronic rejection in human heart transplantation. J Heart Transplant. 1988 Jul-Aug;7(4):292–297. [PubMed] [Google Scholar]
  10. Chomette G., Auriol M., Delcourt A., Karkouche B., Cabrol A., Cabrol C. Human cardiac transplants. Diagnosis of rejection by endomyocardial biopsy. Causes of death (about 30 autopsies). Virchows Arch A Pathol Anat Histopathol. 1985;407(3):295–307. doi: 10.1007/BF00710655. [DOI] [PubMed] [Google Scholar]
  11. Cramer D. V., Qian S. Q., Harnaha J., Chapman F. A., Estes L. W., Starzl T. E., Makowka L. Cardiac transplantation in the rat. I. The effect of histocompatibility differences on graft arteriosclerosis. Transplantation. 1989 Mar;47(3):414–419. doi: 10.1097/00007890-198903000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Cramer D. V., Qian S., Harnaha J., Chapman F. A., Starzl T. E., Makowka L. Accelerated graft arteriosclerosis is enhanced by sensitization of the recipient to donor lymphocytes. Transplant Proc. 1989 Aug;21(4):3714–3715. [PMC free article] [PubMed] [Google Scholar]
  13. Demetris A. J., Zerbe T., Banner B. Morphology of solid organ allograft arteriopathy: identification of proliferating intimal cell populations. Transplant Proc. 1989 Aug;21(4):3667–3669. [PubMed] [Google Scholar]
  14. Emeson E. E., Robertson A. L., Jr T lymphocytes in aortic and coronary intimas. Their potential role in atherogenesis. Am J Pathol. 1988 Feb;130(2):369–376. [PMC free article] [PubMed] [Google Scholar]
  15. Fellström B., Dimeny E., Larsson E., Klareskog L., Tufveson G., Rubin K. Importance of PDGF receptor expression in accelerated atherosclerosis-chronic rejection. Transplant Proc. 1989 Aug;21(4):3689–3691. [PubMed] [Google Scholar]
  16. Gao S. Z., Alderman E. L., Schroeder J. S., Silverman J. F., Hunt S. A. Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. J Am Coll Cardiol. 1988 Aug;12(2):334–340. doi: 10.1016/0735-1097(88)90402-0. [DOI] [PubMed] [Google Scholar]
  17. Gao S. Z., Schroeder J. S., Hunt S., Stinson E. B. Retransplantation for severe accelerated coronary artery disease in heart transplant recipients. Am J Cardiol. 1988 Nov 1;62(13):876–881. doi: 10.1016/0002-9149(88)90885-5. [DOI] [PubMed] [Google Scholar]
  18. Gerrity R. G. The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol. 1981 May;103(2):181–190. [PMC free article] [PubMed] [Google Scholar]
  19. Glagov S., Zarins C., Giddens D. P., Ku D. N. Hemodynamics and atherosclerosis. Insights and perspectives gained from studies of human arteries. Arch Pathol Lab Med. 1988 Oct;112(10):1018–1031. [PubMed] [Google Scholar]
  20. Gown A. M., Tsukada T., Ross R. Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol. 1986 Oct;125(1):191–207. [PMC free article] [PubMed] [Google Scholar]
  21. Grattan M. T., Moreno-Cabral C. E., Starnes V. A., Oyer P. E., Stinson E. B., Shumway N. E. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA. 1989 Jun 23;261(24):3561–3566. [PubMed] [Google Scholar]
  22. Gravanis M. B. Allograft heart accelerated atherosclerosis: evidence for cell-mediated immunity in pathogenesis. Mod Pathol. 1989 Sep;2(5):495–505. [PubMed] [Google Scholar]
  23. Griepp R. B., Stinson E. B., Bieber C. P., Reitz B. A., Copeland J. G., Oyer P. E., Shumway N. E. Control of graft arteriosclerosis in human heart transplant recipients. Surgery. 1977 Mar;81(3):262–269. [PubMed] [Google Scholar]
  24. Hammond E. H., Yowell R. L., Nunoda S., Menlove R. L., Renlund D. G., Bristow M. R., Gay W. A., Jr, Jones K. W., O'Connell J. B. Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications. J Heart Transplant. 1989 Nov-Dec;8(6):430–443. [PubMed] [Google Scholar]
  25. Hardin N. J., Minick C. R., Murphy G. E. Experimental induction of atheroarteriosclerosis by the synergy of allergic injury to arteries and lipid-rich diet. 3. The role of earlier acquired fibromuscular intimal thickening in the pathogenesis of later developing atherosclerosis. Am J Pathol. 1973 Nov;73(2):301–326. [PMC free article] [PubMed] [Google Scholar]
  26. Heldin C. H., Westermark B., Wasteson A. Specific receptors for platelet-derived growth factor on cells derived from connective tissue and glia. Proc Natl Acad Sci U S A. 1981 Jun;78(6):3664–3668. doi: 10.1073/pnas.78.6.3664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Hendrix M. G., Salimans M. M., van Boven C. P., Bruggeman C. A. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol. 1990 Jan;136(1):23–28. [PMC free article] [PubMed] [Google Scholar]
  28. Herskowitz A., Tamura F., Ueda K., Neumann D. A., Slepian M., Rose N. R., Beschorner W. E., Baumgartner W. A., Reitz B. R., Sell K. W. Induction of donor major histocompatibility complex antigens in coronary arterial vessels: mechanism of arterial vasculitis in rat allografts treated with cyclosporine. J Heart Transplant. 1989 Jan-Feb;8(1):11–19. [PubMed] [Google Scholar]
  29. Häyry P., Renkonen R., Leszczynski D., Mattila P., Tiisala S., Halttunen J., Turunen J. P., Partanen T., Rinta K. Local events in graft rejection. Transplant Proc. 1989 Aug;21(4):3716–3720. [PubMed] [Google Scholar]
  30. Johnson D. E., Gao S. Z., Schroeder J. S., DeCampli W. M., Billingham M. E. The spectrum of coronary artery pathologic findings in human cardiac allografts. J Heart Transplant. 1989 Sep-Oct;8(5):349–359. [PubMed] [Google Scholar]
  31. Kosek J. C., Hurley E. J., Lower R. R. Histopathology of orthotopic canine cardiac homografts. Lab Invest. 1968 Jul;19(1):97–112. [PubMed] [Google Scholar]
  32. Laden A. M. The effects of treatment on the arterial lesions of rat and rabbit cardiac allografts. Transplantation. 1972 Mar;13(3):281–290. doi: 10.1097/00007890-197203000-00014. [DOI] [PubMed] [Google Scholar]
  33. Libby P., Salomon R. N., Payne D. D., Schoen F. J., Pober J. S. Functions of vascular wall cells related to development of transplantation-associated coronary arteriosclerosis. Transplant Proc. 1989 Aug;21(4):3677–3684. [PubMed] [Google Scholar]
  34. Marin M. L., Gordon R. E., Hardy M. A., Reemtsma K., Benvenisty A. I. Immunomodulation of vascular endothelium: induction of Ia antigen expression in rejecting venous allografts. Transplant Proc. 1989 Aug;21(4):3709–3713. [PubMed] [Google Scholar]
  35. Martinet Y., Bitterman P. B., Mornex J. F., Grotendorst G. R., Martin G. R., Crystal R. G. Activated human monocytes express the c-sis proto-oncogene and release a mediator showing PDGF-like activity. Nature. 1986 Jan 9;319(6049):158–160. doi: 10.1038/319158a0. [DOI] [PubMed] [Google Scholar]
  36. O'Neill B. J., Pflugfelder P. W., Singh N. R., Menkis A. H., McKenzie F. N., Kostuk W. J. Frequency of angiographic detection and quantitative assessment of coronary arterial disease one and three years after cardiac transplantation. Am J Cardiol. 1989 May 15;63(17):1221–1226. doi: 10.1016/0002-9149(89)90182-3. [DOI] [PubMed] [Google Scholar]
  37. Oguma S., Banner B., Zerbe T., Starzl T., Demetris A. J. Participation of dendritic cells in vascular lesions of chronic rejection of human allografts. Lancet. 1988 Oct 22;2(8617):933–936. doi: 10.1016/s0140-6736(88)92600-1. [DOI] [PubMed] [Google Scholar]
  38. Oz M. C., Roberts C. S., Lemole G. M. Role of lymphostasis in accelerated atherosclerosis in transplanted hearts. Am J Cardiol. 1987 Aug 1;60(4):430–430. doi: 10.1016/0002-9149(87)90279-7. [DOI] [PubMed] [Google Scholar]
  39. Reemtsma K. Vascular immunoobliterative disease: a common cause of graft failure. Transplant Proc. 1989 Aug;21(4):3706–3706. [PubMed] [Google Scholar]
  40. Ross R. Mechanisms of atherosclerosis--a review. Adv Nephrol Necker Hosp. 1990;19:79–86. [PubMed] [Google Scholar]
  41. Ross R., Raines E. W., Bowen-Pope D. F. The biology of platelet-derived growth factor. Cell. 1986 Jul 18;46(2):155–169. doi: 10.1016/0092-8674(86)90733-6. [DOI] [PubMed] [Google Scholar]
  42. Rubin K., Tingström A., Hansson G. K., Larsson E., Rönnstrand L., Klareskog L., Claesson-Welsh L., Heldin C. H., Fellström B., Terracio L. Induction of B-type receptors for platelet-derived growth factor in vascular inflammation: possible implications for development of vascular proliferative lesions. Lancet. 1988 Jun 18;1(8599):1353–1356. doi: 10.1016/s0140-6736(88)92177-0. [DOI] [PubMed] [Google Scholar]
  43. Stamler J. S., Vaughan D. E., Rudd M. A., Mudge G. H., Kirshenbaum J., Young P., Alexander R. W., Loscalzo J. Frequency of hypercholesterolemia after cardiac transplantation. Am J Cardiol. 1988 Dec 1;62(17):1268–1272. doi: 10.1016/0002-9149(88)90272-x. [DOI] [PubMed] [Google Scholar]
  44. Stemerman M. B., Ross R. Experimental arteriosclerosis. I. Fibrous plaque formation in primates, an electron microscope study. J Exp Med. 1972 Oct 1;136(4):769–789. doi: 10.1084/jem.136.4.769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Stemme S., Jonasson L., Holm J., Hansson G. K. Immunologic control of vascular cell growth in arterial response to injury and atherosclerosis. Transplant Proc. 1989 Aug;21(4):3697–3699. [PubMed] [Google Scholar]
  46. Uys C. J., Rose A. G. Pathologic findings in long-term cardiac transplants. Arch Pathol Lab Med. 1984 Feb;108(2):112–116. [PubMed] [Google Scholar]
  47. Yowell R. L., Hammond E. H., Bristow M. R., Watson F. S., Renlund D. G., O'Connell J. B. Acute vascular rejection involving the major coronary arteries of a cardiac allograft. J Heart Transplant. 1988 May-Jun;7(3):191–197. [PubMed] [Google Scholar]
  48. Zoja C., Furci L., Ghilardi F., Zilio P., Benigni A., Remuzzi G. Cyclosporin-induced endothelial cell injury. Lab Invest. 1986 Oct;55(4):455–462. [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES